Sign in
  • AI News
    • Ai Agents
    • Ai and Robotics
    • Ai Companies
    • Ai in art and design
    • Ai in Business
    • Ai in Education
    • Ai in Entertainment
    • AI in Finance
    • Ai in Gaming
    • Ai in Healthcare
    • Ai in Transportation
    • Ai Tech
    • Chatbots and Conversational AI
  • Make Money with AI
  • Chat GPT
  • Ai Tools
  • Writing Prompts
Sign in
Welcome!Log into your account
Forgot your password?
Privacy Policy
Password recovery
Recover your password
Search
  • Sign in / Join
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Ai News Era ainewsera.com
Ai News Era
  • AI News
    • AllAi AgentsAi and RoboticsAi CompaniesAi in art and designAi in BusinessAi in EducationAi in EntertainmentAI in FinanceAi in GamingAi in HealthcareAi in TransportationAi TechChatbots and Conversational AI
      Will Nvidia's budget China AI chip strategy survive Huawei's growing dominance?
      Artificial Intelligence News

      Can Nvidia’s Budget AI Chip Outsmart Huawei’s Rapid Rise?

      Oracle plans $40 billion Nvidia chip deal for AI facility in Texas
      Artificial Intelligence News

      Oracle’s $40B Nvidia Chip Deal: Powering AI Innovation in Texas!

      Ethics in automation: Addressing bias and ensuring compliance in AI systems
      Artificial Intelligence News

      Navigating Ethics in Automation: Tackling AI Bias and Ensuring Compliance

      UK deploys AI to boost Arctic security amid growing threats
      Artificial Intelligence News

      UK Unleashes AI Power to Strengthen Arctic Security Against Rising Threats

  • Make Money with AI
  • Chat GPT
  • Ai Tools
  • Writing Prompts
Home Tags Skin Conditions

Tag: Skin Conditions

Disease course in a patient with TEN (SCORTEN 4) associated with cancer treatment. Disease progression was observed during high-dose intravenous methylprednisolone treatment and the patient developed persistent hyperglycaemia. JAK1i rescue therapy with abrocitinib was initiated on day 4, resulting in visible cessation of progression within 48 h and initial re-epithelialization within 4 days. Top, photographs of the back of the patient, showing the degree of re-epithelialization at the indicated timepoints after hospital admission. Bottom, Treatment schedule. Arrow marks start of abrocitinib treatment. Study: Spatial proteomics identifies JAKi as treatment for a lethal skin disease

Breakthrough Study Reveals JAK Inhibitors as Promising Treatment for Life-Threatening Skin...

Leah Sirama - 10/26/2024 0

EDITOR PICKS

POPULAR POSTS

Google is increasing the features and availability of its AI-powered search.

11/15/2023

Google’s new AI model Gemini: What you need to know

12/08/2023

Adding a New Credential to Your LinkedIn Profile: A Step-by-Step Guide...

01/24/2024

POPULAR CATEGORY

  • Ai Tools1280
  • Ai Companies912
  • Ai and Robotics803
  • AI in Finance742
  • Make Money with AI721
  • Ai in Gaming675
  • Artificial Intelligence News653
  • Ai Tech636
  • Ai in Business571
Ai News Era
ABOUT US
FOLLOW US
  • Privacy Policy
  • About Me
  • Contact Us
  • Sitemap
©